Skip to main content

Advertisement

SpringerLink
Log in

A Promising Diagnostic Role of Immunohistochemical Expression of Insulin-Like Growth Factor II mRNA Binding Protein 3 (IMP3) in Pancreatic Lesions Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) Cytology

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Poor prognosis and short survival of patients harboring pancreatic cancer emerge how advanced disease it is. In a trial to achieve the earliest and most accurate diagnosis to manage this progressive disease, we proposed that using endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) with an adjuvant diagnostic immunohistochemical marker would give better diagnostic results. IMP3 has gained recently wide attention, as many studies found that IMP3 has not only diagnostic but also prognostic role in different types of malignancies.

Aim of the Study

This prospective work is to assess the diagnostic role of EUS-FNA combined with the immunohistochemical expression of IMP3 on different benign and malignant pancreatic lesions.

Material and Method

The included pancreatic lesions (n = 140) were obtained by EUS-FNA technique and stained for IMP3 immunohistochemically. Paraffin blocks from patients who underwent excision (n = 92) or core biopsies (n = 48) were performed for confirming diagnosis.

Results

The combined method for diagnosis showed that IMP3 was positive in 78.7%, 91.7%, 100% PAC, mucinous neoplasm with high grade dysplasia, and IPMN with high grade dysplasia, respectively, while almost all benign lesions showed negative IMP3. Also, this method showed sensitivity (78.26%), specificity (95.83%), and accuracy (84.3%).

Conclusion

EUS-FNA cytology with IMP3 could be a reliable diagnostic tool especially for assessment of malignant pancreatic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. American Cancer Society. Facts & figures 2021. Atlanta, Ga: American Cancer Society; 2021.

    Google Scholar 

  2. Howlader N, Noone AM, Krapcho M, et al (eds). SEER cancer statistics review, 1975–2017, National Cancer Institute, Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2018 SEER data submission, posted to the SEER website, April 2019.

  3. Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas. 2013;42(1):20–6.

    Article  PubMed  Google Scholar 

  4. Nielsen FC, Nielsen J, Christiansen J. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl. 2001;234:93–9.

    Article  CAS  PubMed  Google Scholar 

  5. Mueller-Pillasch F, Pohl B, Wilda M, Lacher U, Beil M, Wallrapp C, Hameister H, Knöchel W, Adler G, Gress TM. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev. 1999;88(1):95–9.

    Article  CAS  PubMed  Google Scholar 

  6. Yan J, Wei Q, Jian W, Qiu B, Wen J, Liu J, Fu B, Zhou X, Zhao T. IMP3 predicts invasion and prognosis in human lung adenocarcinoma. Lung. 2016;194:137–46.

    Article  CAS  PubMed  Google Scholar 

  7. Lok T, Chen L, Lin F, Wang HL. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Hum Pathol. 2014;45:394–400.

    Article  CAS  PubMed  Google Scholar 

  8. Damasceno EA, Carneiro FP, Magalhães AV, Carneiro MV, Takano GH, Vianna LM, Seidler HB, Castro TM, Muniz-Junqueira MI, Amorim RF, Ferreira VM. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status. J Cancer Res Clin Oncol. 2014;140:2163–8.

    Article  CAS  PubMed  Google Scholar 

  9. Li D, Yan D, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol. 2009;16(12):3499–506.

    Article  PubMed  Google Scholar 

  10. Burdelski C, Jakani-Karimi N, Jacobsen F, Möller-Koop C, Minner S, Simon R, Sauter G, Steurer S, Clauditz TS, Wilczak W. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: a tissue microarray study on 8,877 human cancers and normal tissues. Oncol Rep. 2018;39(1):3–12.

    CAS  PubMed  Google Scholar 

  11. Yan J, Wei Q, Jian W, Qiu B, Wen J, Liu J, Fu B, Zhou X, Zhao T. IMP3 predicts invasion and prognosis in human lung adenocarcinoma. Lung. 2016;194(1):137–46.

    Article  CAS  PubMed  Google Scholar 

  12. Pasiliao CC, Chang CW, Sutherland BW, Valdez SM, Schaeffer D, Yapp DT, Ng SS. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion. BMC Cancer. 2015;15:266.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Elshafey MR, Ahmed RA, Mourad MI, Gaballah ET. The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands. Cancer Biol Med. 2016;13(2):286–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tanaka H, Kawashima H, Ohno E, Ishikawa T, Iida T, Ishikawa E, Furukawa K, Nakamura M, Honda T, Shimoyama Y, Miyahara R, Kawabe N, Kuzuya T, Hashimoto S, Ishigami M, Hirooka Y, Fujishiro M. Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis. BMC Gastroenterol. 2021;21(1):224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Barton VN, Donson AM, Birks DK, Kleinschmidt-DeMasters BK, Handler MH, Foreman NK, Rush SZ. Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma. J Neuropathol Exp Neurol. 2013;72(5):442–9.

    Article  CAS  PubMed  Google Scholar 

  16. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. The American J Surg Pathol. 2005;29(2):188–95.

    Article  Google Scholar 

  17. Wang BJ, Wang L, Yang SY, Liu ZJ. Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions. Clin Transl Oncol. 2015;17(3):215–22.

    Article  CAS  PubMed  Google Scholar 

  18. Wang Q, Wang T, Wang Z, Zheng H. Diagnostic value of IMP3 in pancreatic cancer: a meta-analysis [Retraction]. Int J Clin Exp Med. 2016;9(6):12417.

  19. Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol. 2008;32(2):304–15.

    Article  PubMed  Google Scholar 

  20. Yantiss RK, Cosar E, Fischer AH. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. Acta Cytol. 2008;52(2):133–8.

    Article  PubMed  Google Scholar 

  21. Zhao H, Mandich D, Cartun RW, Ligato S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol. 2007;35(11):700–4.

    Article  PubMed  Google Scholar 

  22. Liu H, Shi J, Anandan V, Wang HL, Diehl D, Blansfield J, Gerhard G, Lin F. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Arch Pathol Lab Med. 2012;136(6):601–9.

    Article  PubMed  Google Scholar 

  23. Ezzat NE, Tahoun NS, Ismail YM. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma. J Egypt Natl Canc Inst. 2016;28(4):229–34.

    Article  PubMed  Google Scholar 

  24. Senoo J, Mikata R, Kishimoto T, Hayashi M, Kusakabe Y, Yasui S, Yamato M, Ohyama H, Sugiyama H, Tsuyuguchi T, Yoshitomi H, Ohtsuka M, Maeda J, Ota S, Nakatani Y, Kato N. Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases. Pancreatology. 2018;18:176–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Hayam E. Rashed, Awatef N. Nasr, Nora T. Wasfi & Nelly M. Said

  2. Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Ramy ElHendawy

Authors
  1. Hayam E. Rashed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Awatef N. Nasr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nora T. Wasfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ramy ElHendawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nelly M. Said
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hayam E. Rashed.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashed, H.E., Nasr, A.N., Wasfi, N.T. et al. A Promising Diagnostic Role of Immunohistochemical Expression of Insulin-Like Growth Factor II mRNA Binding Protein 3 (IMP3) in Pancreatic Lesions Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) Cytology. J Gastrointest Canc 54, 96–103 (2023). https://doi.org/10.1007/s12029-021-00770-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00770-3

Keywords

Search

Navigation